Autori: Xu B
| Naslov | OPTIMAL: a multinational phase III study of oral paclitaxel (DHP107) versus intravenous weekly paclitaxel in HER2-negative recurrent or metastatic breast cancer (Article) |
| Autori | Xu B ... Kostic S ... Milenkovic D ... (broj koautora 21) |
| Info | ANNALS OF ONCOLOGY, (2026), vol. 37 br. 7, str. 936-945 |
| Projekat | Daehwa Pharmaceutical Co., Ltd.; Haihe Biopharma Co., Ltd. [2017-1216] |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: |
